ASX:ACR Acrux (ACR) Stock Price, News & Analysis → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free ACR Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume4,000 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield11.66%Price TargetN/A Stock AnalysisStock Analysis Get Acrux alerts: Email Address Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now About Acrux Stock (ASX:ACR)Acrux Limited, together with its subsidiaries, develops and commercializes generic and topical pharmaceuticals in Australia, Europe, the United States, and internationally. The company offers testosterone solutions, such as oral tablets, buccal tablets, subcutaneous pellets, transdermal patches, injections, and topical gels for treatment of males. It also provides estradiol transdermal sprays for women under the Evamist and Lenzetto brand names for the treatment of flushes associated with menopause; and lidocaine and prilocaine cream, a generic version of EMLA cream, which is indicated as a topical anaesthetic for use on normal intact skin for local analgesia, and genital mucous membranes for superficial minor surgery and as a pre-treatment for infiltration anaesthesia. The company was incorporated in 1998 and is based in West Melbourne, Australia.Read More Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now ACR Stock News HeadlinesApril 24, 2024 | msn.comCheck Up: Big breakthrough in acne treatment, and recent ASX biotech winnersApril 8, 2024 | msn.comYou Won't Find Any Other Arc'teryx Deals This Good Anytime SoonApril 24, 2024 | InvestorPlace (Ad)The #1 Crypto for 20245 Tiny Cryptos That Could Soar During 2024 Crypto Bull Run One of the first ever crypto millionaires who bought Bitcoin when it was trading for just $5 in 2011 is back with his next huge prediction. A newly approved government regulation is set to flood trillions of dollars into the crypto markets, leading to the FINAL crypto bull run. One of the "Kings of Crypto" has revealed five tiny cryptos that could soar over the course of 2024. Potentially resulting in gains as big as 10X, 50X, or even 100X over the next 12 months.April 7, 2024 | msn.comHot Money Monday: Momentum trading vs investing, and how both can profit using these 3 signalsApril 2, 2024 | msn.comGuess which ASX healthcare stock is rocketing 110% on US product launchApril 2, 2024 | msn.comASX Health Stocks: Acrux jumps 70pc after launching its acne gel in the USApril 1, 2024 | cbsnews.comExplosive garage-psych band Meatbodies plays new songs at the ChapelMarch 26, 2024 | msn.comDanner Mountain Light II review: a sturdy classic for modern hikersApril 24, 2024 | InvestorPlace (Ad)The #1 Crypto for 20245 Tiny Cryptos That Could Soar During 2024 Crypto Bull Run One of the first ever crypto millionaires who bought Bitcoin when it was trading for just $5 in 2011 is back with his next huge prediction. A newly approved government regulation is set to flood trillions of dollars into the crypto markets, leading to the FINAL crypto bull run. One of the "Kings of Crypto" has revealed five tiny cryptos that could soar over the course of 2024. Potentially resulting in gains as big as 10X, 50X, or even 100X over the next 12 months.February 5, 2024 | ca.style.yahoo.com6 best winter boots for Canadian winters — how to stay warm in 5°C to -50°CJanuary 29, 2024 | msn.comHot Money Monday: How momentum investors can exploit overconfidence and skepticism in the marketJanuary 21, 2024 | foxnews.comGoogle engineer found 'spattered in blood' following alleged murder of wife in upscale California home: policeDecember 13, 2023 | bizjournals.comTaste of Belgium reveals brand revitalization with new University Heights Bistro locationDecember 7, 2023 | msn.comRoad repairs to look out for in San Diego this monthDecember 3, 2023 | msn.comHot Money Monday: Momentum trading has been a popular strategy for decades, and here’s how you can use itNovember 29, 2023 | msn.comAdidas Terrex Free Hiker GTX Hiking Shoes 2.0 review: boots with bounceNovember 24, 2023 | msn.comThe 10 Best Hiking Boots for Men to Wear on Any Outdoor AdventureNovember 22, 2023 | finance.yahoo.comAcrux Limited's (ASX:ACR) CEO Will Probably Find It Hard To See A Huge Raise This YearNovember 21, 2023 | msn.comStreet Resurfacing Planned in Clairemont, Mira Mesa, Torrey Hills, La Jolla and University CityNovember 21, 2023 | msn.comSome San Diego streets are getting a holiday makeover. Here’s whereNovember 17, 2023 | yahoo.comThe Weekly Covet: The Best Boots for Fall & Winter, According to T&C EditorsNovember 6, 2023 | msn.comThe 81 Best Gifts for Outdoorsmen, Tested and Reviewed by an Adventure EnthusiastNovember 3, 2023 | yahoo.comThe 15 Best Men's Hiking Boots for Any Kind of TerrainOctober 25, 2023 | msn.com13 best women’s hiking boots for rambling and trekkingOctober 20, 2023 | msn.comThe 80 Best Gifts for Outdoorsmen, Tested and Reviewed by an Adventure EnthusiastSeptember 9, 2023 | msn.comSalomon Elixir Mid Gore-Tex Boots review: Chunky hooves with a rock-and-roll soleAugust 13, 2023 | thetimes.co.uk‘Poker star’s’ luxury yacht sunk by fireSee More Headlines Receive ACR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Acrux and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/21/2019Today4/24/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolASX:ACR CUSIPN/A CIKN/A Webwww.acrux.com.au Phone+61-3-83790100FaxN/AEmployees2,018Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-7,660,000.00 Net Margins-6.21% Pretax MarginN/A Return on Equity-12.21% Return on Assets-15.12% Debt Debt-to-Equity Ratio40.07 Current Ratio2.09 Quick Ratio2.89 Sales & Book Value Annual Sales$11.42 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow1.57 Book ValueA$0.02 per share Price / BookN/AMiscellaneous Outstanding Shares290,720,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta1.19 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesMr. Michael John Kotsanis B.Sc. (Age 58)BSc, GradDipBus, MBus, CEO, MD & Executive Director Comp: $517.86kMs. Joanna Johnson B.E.BEc, ICAA, CFO & Company SecretaryKey Competitors180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF45525 (CUR.TO)TSE:CUR60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFView All CompetitorsInsidersRoss DobinsonSold 418,851 sharesTotal: $23,036.81 ($0.06/share)Timothy OldhamBought 414,561 shares on 12/20/2023Total: $18,655.25 ($0.05/share)Geoffrey BrookeSold 1,062,946 sharesTotal: $52,084.35 ($0.05/share)Ross DobinsonSold 237,610 sharesTotal: $10,217.23 ($0.04/share)Ross DobinsonBought 237,610 shares on 8/30/2023Total: $11,405.28 ($0.05/share) ACR Stock Analysis - Frequently Asked Questions How were Acrux's earnings last quarter? Acrux Limited (ASX:ACR) posted its earnings results on Thursday, February, 21st. The company reported ($0.02) earnings per share for the quarter. Acrux had a negative trailing twelve-month return on equity of 12.21% and a negative net margin of 6.21%. Is Acrux a good dividend stock? Acrux (ASX:ACR) pays an annual dividend of A$0.09 per share and currently has a dividend yield of 11.66%. ACR has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. What other stocks do shareholders of Acrux own? Based on aggregate information from My MarketBeat watchlists, some companies that other Acrux investors own include ANZ Group (ANZ), Lynas Rare Earths (LYC), Altium (ALU), Atlas Iron (AGO), Hugo Boss (BOSS), BHP Group (BHP), Beacon Roofing Supply (BECN), Billabong International (BBG), Abraxas Petroleum (AXAS) and Ausdrill (ASL). This page (ASX:ACR) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority Goldtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acrux Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
